Potential new treatment for sepsis
Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results.
Jan 15, 2026
0
2
Public Health: News and Research on Clinical Trials, Phase III as Topic
MeSH tree: N06.850.520.450.250.250.220
New ALS drug stabilizes decline with a trend toward improved strength and mobility for some
Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, researchers from Washington ...
Dec 23, 2025
0
24
FDA approves Exdensur for severe asthma
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.
Dec 22, 2025
0
0
US health regulator rejects MDMA treatment for PTSD, for now
US health regulators on Friday denied an application for treating post-traumatic stress disorder (PTSD) with the drug MDMA, commonly known as ecstasy, saying more investigation needed to be done.
Aug 10, 2024
0
31
Tacrolimus microemulsion has good efficacy, safety for scalp psoriasis
For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.
Mar 6, 2024
0
0
